Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 341, Issue 3, Pages 227-231Publisher
ELSEVIER SCIENCE INC
DOI: 10.1097/MAJ.0b013e3181df9055
Keywords
Colorectal cancer; Metabolic syndrome; Hyperinsulinemia; Obesity
Categories
Ask authors/readers for more resources
Currently, significant amount of epidemiologic evidence is present to suggest that metabolic syndrome increases the risk of developing colorectal cancer. This evidence is based on studies of the evaluate determinants of the metabolic syndrome (obesity), clinical consequences of metabolic syndrome (type 2 diabetes and hypertension) and serum component of metabolic syndrome (hypertriglyceridemia, hyperglycemia and low high-density lipoprotein cholesterol), as well as markers of hyperinsulinemia. Although the exact pathogenesis of this relationship is unknown, it seems that hyperinsulinemia may play a pivotal role in increasing CRC risk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available